Philadelphia, Pennsylvania--(Newsfile Corp. - April 1, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of Teladoc Health, Inc. (NYSE: TDOC). The investigation concerns whether the Company and certain of its officers and directors violated the federal securities laws and breached their fiduciary duties.

If you purchased Teladoc Health, Inc. (NYSE: TDOC) stock prior to July 28, 2023, and still hold shares today, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever. Please visit https://grabarlaw.com/the-latest/teladoc-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.

Why? On March 31, 2026, the United States District Court for the Southern District of New York denied in part defendants' motion to dismiss an underlying securities fraud class action complaint against Teladoc Health, Inc. (NYSE: TDOC) and certain of its officers - and allowed certain securities fraud claims to proceed.

According to that complaint, Defendants made materially false and misleading statements and omissions to investors regarding BetterHelp's customer acquisition costs and planned seasonal performance. Unbeknownst to investors, however, BetterHelp's customer acquisition costs in the social media channel had materially increased because BetterHelp had saturated that channel. Thus, BetterHelp's ad spend in the social media channel had become significantly more expensive, thereby materially reducing profits.

In allowing the underlying securities fraud class action to move forward, the Court determined that certain allegations presented by the suing investors also made it plausible the company knew about data the platform's customer acquisition costs were rising as early as July 2023, including statements from Murthy that leadership was monitoring BetterHelp's ad spend "hourly and daily." "Plaintiffs have adequately alleged defendants' comments and other circumstances plausibly plead an inference of scienter [knowing falsity or reckless disregard for the truth] for the actionable statements 'at least as compelling as any opposing inference one could draw from the facts alleged…."

What Can You Do Now? If you purchased or otherwise acquired Teladoc Health, Inc. (NYSE: TDOC) securities prior to January 28, 2023 and still hold shares today, please visit https://grabarlaw.com/the-latest/teladoc-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you whatsoever.

#TDOC #Teladoc $TDOC

Attorney Advertising Disclaimer

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/290876

Source: Grabar Law Office